Learn More
Medchemexpress LLC Synstatin (92-119) | 1259384-47-8 | 99.4% | 3032.27 | 5 MG

Supplier: Medchemexpress LLC HYP51335MG
Synstatin (92-119) is an inhibitor of αvβ3/αvβ5 integrins and IGF1R, exhibiting anti-angiogenic, anti-proliferative, antioxidant, and anti-tumor activities. It competitively blocks the capture of αvβ3/αvβ5 integrins and IGF1R by syndecan-1, disrupting the formation of the syndecan-1: integrin: IGF1R ternary complex. It also inhibits integrin activation, talin-mediated signaling, and VEGF-induced angiogenesis, making it suitable for cancer and hepatocellular carcinoma research.
- Directly inhibits assembly of Sdc1:αvβ3 integrin:IGF1R ternary complex
- Binds to αvβ3 integrin, αvβ5 integrin, and IGF1R on activated vascular endothelial cells
- Inhibits αvβ3-dependent adhesion and migration of tumor cells
- Inhibits VEGF- and αvβ3-dependent angiogenesis
- Reduces hepatocellular carcinoma progression in thioacetamide-induced rats
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.